THE INSTITUTE OF MEDICAL SCIENCE, THE UNIVERSITY OF TOKYO

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease (SCD) locus in xenograft mouse and non-human primate models

Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and co-expressed truncated erythropoietin receptor

Report of The External Review Committee 2021 has been released(PDF:4.5MB)

The recipients of IMSUT Outstanding Student Publication Award FY2020 have been decided Open a new window

Pooping out miracles: scientists reveal mechanism behind fecal microbiota transplantation-Osaka City University and IMSUT demonstrate fecal microbiota transplantation (FMT) success by revealing the coordinated effort of bacteriophages (phages) and their host bacteria in restoring human intestinal flora-

FY2021 Online English Seminar Series Open a new window

48th IMSUT Founding Commemorative Symposium "Advance in gene therapies and genome editing tools"

Hematopoietic stem cell-targeted gene therapy for sickle cell disease

Novel expansion platforms enhance HSC gene editing

Announcement of FY 2020 Young Researchers Symposium of International Joint research Open a new window

Make a Gift Open a new window

Support for International Affairs Office Open a new window

Research Platform Office "Supporting Life Science Research" Open a new window